Elevated Serum Transforming Growth Factor β1 Levels in Epstein-Barr Virus-Associated Diseases and Their Correlation with Virus-Specific Immunoglobulin A (IgA) and IgM
- 1 March 2000
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 74 (5) , 2443-2446
Abstract
Transforming growth factor β (TGF-β) is an immunosuppressive cytokine which can induce immunoglobulin A (IgA) switch and Epstein-Barr virus (EBV) replication in latently infected cells. Here we report elevated serum levels of TGF-β in various EBV-associated diseases correlating positively with EBV-specific IgA titers and negatively with IgM titers, suggesting a role for this cytokine in the pathogenesis of these diseases.Keywords
This publication has 32 references indexed in Scilit:
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Mucosal immunology: new frontiersImmunology Today, 1996
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- Endogenous TGF‐β contributes to the induction of the EBV lytic cycle in two burkitt lymphoma cell linesInternational Journal of Cancer, 1994
- Interleukin-10Annual Review of Immunology, 1993
- Immunoglobulin A-Induced Shift of Epstein-Barr Virus Tissue TropismScience, 1992
- Epstein — Barr virus vaccinesVaccine, 1992
- Salivary and serum IgA antibodies to the epstein—barr virus glycoprotein gp340: incidence and potential for virus neutralizationInternational Journal of Cancer, 1991
- Epstein‐Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineageEuropean Journal of Immunology, 1987
- Protection of cottontop tamarins against Epstein–Barr virus-induced malignant lymphoma by a prototype subunit vaccineNature, 1985